Current issues in the regulation of human tissue-engineering products in the European Union

Tissue Engineering

Volumn 11, Issue 11-12, 2005, Pages 1905-1911

  Heinonen, Maarit ^a,b   Oila, Outi ^a   Nordström, Katrina ^a  

^a AALTO UNIVERSITY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIALS; CELLS; MEDICAL APPLICATIONS; PRODUCT DEVELOPMENT; RISK ASSESSMENT; TISSUE CULTURE;

BIOLOGICAL RISKS; LIFE SCIENCES; PRODUCT SAFETY; TISSUE ENGINEERING (TE);

BIOMEDICAL ENGINEERING;

BIOMATERIAL;

ARTICLE; CANCER RISK; CARCINOGENESIS; ETHICS; EUROPEAN UNION; GRAFT REJECTION; HUMAN; HUMAN TISSUE; INFECTION RISK; PATENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAFETY; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; CLINICAL TRIALS; CONSUMER PRODUCT SAFETY; EUROPEAN UNION; HUMANS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TISSUE ENGINEERING;

EID: 31044433718     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2005.11.1905     Document Type: Article

References (13)

1. Proposal for a harmonized regulatory framework on human tissue engineering products: DG Enterprise consultation paper, April 6, 2004. Available at: http://pharmacos. eudra.org/F3/human-tissue/Consultation_document.pdf.
2. Nieminen, O., Nordström, K., and Kurki, P. Tissue engineering: Viable technologies seeking regulation-a Finnish perspective. Drug Discov. Today 9, 387, 2004.
3. Mason, J. Qualitative Researching. Towbridge, Wiltshire, UK: Redwood Books, 1996.
4. Nieminen, O., Rahkamo, L., and Nordstrom, K. Biotechnology regulation: Views of the authorities, investors and product developers in Finland. Drug Inf. J. 3, 253, 2004.
5. Smith, M.E. Manufacturing and control of cellular and combination therapies. Regul. Affairs Focus May 12, 2003.
6. Orive, G., Hernández, M., Gascón, A.R., Igartua, M., and Pedraz, J.L. Controversies over stem cell research. Trends Biotechnol. 21, 109, 2003.
7. Parker, S. Cell therapy: European legal and regulatory implications. J. Commerc. Biotechnol. 8, 66, 2001.
8. Lysaght, J.M., and Hazelhurst, A.L. Tissue engineering: The end of the beginning. Tissue Eng. 10, 309, 2004.
9. Bock, A.K., Ibarreta, D., and Rodriguez-Cerezo, E. Human tissue-engineered products: Today's markets and future prospects. IPTS Publications, 2003. Available at http://www.jrc.es/home/publications/ publication.cfm?pub = 1127 (accessed December 2005).
10. Foster, L., Nanu, D., and Alcock, S. Patenting in the biopharmaceutical industry-comparing the US with Europe. Drug Plus Int. 1, 2002. Available at http://scientific.thomson.com/knowtrend/ipmatters/pii/8180019/ (accessed December 2005).
11. Opinion of the European Group on Ethics in Science and New Technologies to the European Commission No 16, May 7, 2002: Ethical Aspects of Patenting Inventions Involving Human Stem Cells.
12. Caulfield, T.A. From human genes to stem cells: New challenges for patent law. Trends Biotechnol. 21, 101, 2003.
13. Senker, J. Human tissue-engineered products: Today's markets and future prospects-legal situation and socio-economic impacts of tissue engineering. Final Report, SPRU Science and Technology Policy Research, Brighton 2003.